Error occurred while parsing the model response.
Error parsing response
Stay Updated with Our Daily Newsletter
Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.
Clinical Trials
Related research and studies
Highlighted Clinical Trials
Eli Lilly and Company
Posted 1/20/2015
Taiho Oncology, Inc.
Posted 11/25/2020
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
Taiho Oncology, Inc.
Posted 6/17/2012
Eli Lilly and Company
Posted 12/1/2010
Eli Lilly and Company
Posted 12/2/2010
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Posted 1/24/2019
Sources
Ramucirumab Plus TAS-102 Fails to Improve OS in Heavily Pretreated mCRC - OncLive
onclive.comSep 15, 2024
Trending News
Daily Pharma Insights
Get curated, high-impact pharmaceutical news delivered to your inbox every morning.
- Critical clinical trial updates & results
- Regulatory approvals & strategic partnerships
- Market access decisions & commercial developments
© Copyright 2025. All Rights Reserved by MedPath